Ledger.Open graph →
SEC Form D · filed June 5, 2014

Gemmus Pharma Inc

Offering
$3.3M
Sold
$3.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Christopher Dunn · WASHINGTON, Washington, D.C.DirectorMarc Rubin · Brighton, MADirectorChristopher Dunn · Kansas City, MODirectorMarc Rubin · Reston, VADirectorWilliam Guilford · San Francisco, CAExec · DirectorWilliam Holstein · San Francisco, CAExecLarry Miller · Hopkinton, MADirectorDaryl Faulds · San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗